Wells Fargo Starts Alexion Pharmaceuticals (ALXN) at Market Perform; Share Street Optimism for Soliris
Tweet Send to a Friend
Wells Fargo initiates coverage on Alexion Pharmaceuticals (NASDAQ: ALXN) with a Market Perform. Valuation Range: $74-$78.
Wells analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
